8 Results

People

  1. Brady
    Brady
  2. Lee
    Lee
  3. Lee
    Lee
  4. Budhu
    Budhu
  5. Eil
    Eil
  6. Gasmi
    Gasmi
  7. Hellmann
    Hellmann
  8. Hirschhorn Cymerman
    Hirschhorn Cymerman
  9. Latouche
    Latouche
  10. Liu
    Liu

Groups

  1. Department of Medicine (3)
  2. Melanoma Disease Management Team (3)
  3. Sloan Kettering Institute Postdocs (3)
  4. Surgery (2)
  5. Biostatistics Service (1)
  6. Center for Hematologic Malignancies (1)
  7. Division of Subspecialty Medicine (1)
  8. Epidemiology and Biostatistics (1)
  9. GSK Faculty (1)
  10. Hematologic Malignancies Service (1)
  1. "cd4+ t cells"
Formats
  1. Journal Article (7)
  2. Book Section (1)
Groups
  1. Department of Medicine (3)
  2. Melanoma Disease Management Team (3)
  3. Sloan Kettering Institute Postdocs (3)
  4. Surgery (2)
  5. Biostatistics Service (1)
  6. Center for Hematologic Malignancies (1)

More Groups

People
  1. Fei Lee (2)
  2. Janet Lee (2)
  3. Mary Brady (2)
  4. Alexander Ploss (1)
  5. Billel Gasmi (1)
  6. Bruno Moltedo Gonzalez (1)

More People

Years
  1. 2024 (1)
  2. 2021 (1)
  3. 2018 (1)
  4. 2008 (1)
  5. 2006 (1)
  6. 2004 (1)

More Years

Publications
  1. Cancer Cell (1)
  2. Cancer Immunology, Immunotherapy (1)
  3. Clinical Immunology (1)
  4. Immunology (1)
  5. International Journal of Cancer (1)
  6. Journal of Immunotherapy (1)

More Publications

Publishers
  1. Cell Press (1)
  2. Elsevier Inc. (1)
  3. John Wiley & Sons (1)
  4. Lippincott Williams & Wilkins (1)
  5. Springer (1)
  6. Wiley Blackwell (1)

More Publishers

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Convergence, plasticity, and tissue residence of regulatory T cell response via TCR repertoire prism
    Journal Article

    Nakonechnaya, T. O.; Moltedo, B.; Putintseva, E. V.; Leyn, S.; Bolotin, D. A.; Britanova, O. V.; Shugay, M.; Chudakov, D. M.
    eLife (2024)

    Fulltext@MSK | Save
  • CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function
    Journal Article

    Whiteside, S. K.; Grant, F. M.; Gyori, D. S.; Conti, A. G.; Imianowski, C. J.; Kuo, P.; Nasrallah, R.; Sadiyah, F.; Lira, S. A.; Tacke, F.; more...
    Immunology (2021)

    Fulltext@MSK | Save
  • Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity
    Journal Article

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Patients with Epstein Barr virus-positive lymphomas have decreased CD4 + T-cell responses to the viral nuclear antigen 1
    Journal Article

    Heller, K. N.; Arrey, F.; Steinherz, P.; Portlock, C.; Chadburn, A.; Kelly, K.; Münz, C.
    International Journal of Cancer (2008)

    Fulltext@MSK | Save
  • Identification of two Melan-A CD4+ T cell epitopes presented by frequently expressed MHC class II alleles
    Journal Article

    Godefroy, E.; Scotto, L.; Souleimanian, N. E.; Ritter, G.; Old, L. J.; Jotereau, F.; Valmori, D.; Ayyoub, M.
    Clinical Immunology (2006)

    Fulltext@MSK | Save
  • Memory
    Book Section

    Ploss, A.; Pamer, E. G.
    In Kaufmann, S. H. E. (Eds.) Novel Vaccination Strategies (2004)

    Fulltext@MSK | Save
  • Restoration of alloreactivity of melanoma by transduction with B7.1
    Journal Article

    Brady, M. S.; Lee, F.; Eckels, D. D.; Ree, S. Y.; Latouche, J. B.; Lee, J. S.
    Journal of Immunotherapy (2000)

    Fulltext@MSK | Save
  • CD4+ T cells kill HLA-class-II-antigen-positive melanoma cells presenting peptide in vitro
    Journal Article

    Brady, M. S.; Lee, F.; Petrie, H.; Eckels, D. D.; Lee, J. S.
    Cancer Immunology, Immunotherapy (2000)

    Fulltext@MSK | Save